期刊文献+

Prevalence of Anti-endothelial Cell Antibodies in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases 被引量:7

Prevalence of Anti-endothelial Cell Antibodies in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases
下载PDF
导出
摘要 Objective To investigate the prevalence of anti-endothelial cell antibodies (AECAs) in the sera of connective tissue diseases (CTD) patients with pulmonary arterial hypertension (PAH) and its correlation with clinical manifestations. Methods AECAs in sera of 39 CTD patients with PAH,22 CTD patients without PAH,and 10 healthy donors as controls were detected with Western blotting. The prevalence of different AECAs in different groups was compared and its correlation with clinical manifestations was also investigated. Results The prevalence of AECAs was 82.1% in CTD patients with PAH,72.7% in CTD patients without PAH,and 20.0% in healthy donors. Anti-22 kD AECA was only detected in CTD patients with PAH (15.4%). Anti-75 kD AECA was more frequently detected in CTD patients with PAH than in those without PAH (51.3% vs. 22.7%,P<0.05). In CTD patients with PAH,anti-75 kD AECA was more frequently detected in those with Raynaud’s phenomenon or with positive anti-RNP antibody. Conclusion AECAs could be frequently detected in CTD patients with or without PAH,while anti-22 kD and anti-75 kD AECA might be specific in CTD patients with PAH. Objective To investigate the prevalence of anti-endothelial cell antibodies (AECAs) in the sera of connective tissue diseases (CTD) patients with pulmonary arterial hypertension (PAH) and its correlation with clinical manifestations. Methods AECAs in sera of 39 CTD patients with PAH,22 CTD patients without PAH,and 10 healthy donors as controls were detected with Western blotting. The prevalence of different AECAs in different groups was compared and its correlation with clinical manifestations was also investigated. Results The prevalence of AECAs was 82.1% in CTD patients with PAH,72.7% in CTD patients without PAH,and 20.0% in healthy donors. Anti-22 kD AECA was only detected in CTD patients with PAH (15.4%). Anti-75 kD AECA was more frequently detected in CTD patients with PAH than in those without PAH (51.3% vs. 22.7%,P0.05). In CTD patients with PAH,anti-75 kD AECA was more frequently detected in those with Raynaud’s phenomenon or with positive anti-RNP antibody. Conclusion AECAs could be frequently detected in CTD patients with or without PAH,while anti-22 kD and anti-75 kD AECA might be specific in CTD patients with PAH.
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2010年第1期27-31,共5页 中国医学科学杂志(英文版)
基金 Supported by Chinese National Key Technology R&D Program (2006BAI01A07, 2008BAI59B02) Clinical Grant of Chinese Medicine Association (08010270105)
关键词 结缔组织 肺动脉高压 内皮细胞 患者 抗体 多环芳烃 临床表现 PAH connective tissue diseases pulmonary arterial hypertension anti-endothelial cell antibodies
  • 相关文献

参考文献1

二级参考文献16

  • 1Lindquist KI, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol, 1971, 9:753-760.
  • 2Praprotnik S, Blank M, Memni PL, et al. Classification of antiendothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells. Arthritis Rheum, 2001, 44: 1484-1494.
  • 3Hunder GG, Arend WP, Bloeh DA, et al. The American College of Rheumatology 1990 eriteria for the classification of vasculitis.Introduction. Arthritis Rheum, 1990,33 : 1065-1067.
  • 4International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's Disease. Lancet, 1990,335 : 1078-1080.
  • 5Lee KH, Chung HS, Kim HS, et al. Human alpha-enolase from endothelial cell as a target antigen of anti-endothelial cell antibody in Behect's disease. Arthritis Rheum, 1996, 39:758-766.
  • 6Del Papa N, Conforti G, Gambini D, et aL Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol, 1994, 70:211-216.
  • 7Li JS, Liu MF, Lei HY. Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erthematosus: a potential marker for disease activity. Clin Immunal Immunopathal,1996,79:211-216.
  • 8Frampton G, Moriya S, Pearson JD, et al. Identification of candidate of endothelial cell in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein PO as an endothelial cell autoantigen. Rheumatology,2000, 39 : 1114-1120.
  • 9Yazici ZA, Behrendt M, Cooper D. The identification of endothelial cell autoantigens. J Autoimmun, 2000, 15:41-49.
  • 10Gitlits VM, Toh BH, Sentry JW. Disease association, origin, and clinical relevance of autoantibodies to the glycolytic enzyme enolase.J Investig Med 2001 ; 49: 138-45.

共引文献12

同被引文献36

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部